Follow this preprint
Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens
View ORCID ProfileMatthias Becker, Monika Strengert, Daniel Junker, Tobias Kerrinnes, Philipp D. Kaiser, Bjoern Traenkle, Heiko Dinter, Julia Häring, Anne Zeck, Frank Weise, Andreas Peter, Sebastian Hörber, Simon Fink, Felix Ruoff, Tamam Bakchoul, Armin Baillot, Stefan Lohse, Markus Cornberg, Thomas Illig, Jens Gottlieb, Sigrun Smola, André Karch, Klaus Berger, Hans-Georg Rammensee, Katja Schenke-Layland, Annika Nelde, Melanie Märklin, Jonas S. Heitmann, Juliane S. Walz, Markus Templin, Thomas O. Joos, Ulrich Rothbauer, Gérard Krause, View ORCID ProfileNicole Schneiderhan-Marra
doi: https://doi.org/10.1101/2020.07.17.20156000
Now published in Nature Communications doi: 10.1038/s41467-021-20973-3
Matthias Becker
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Monika Strengert
2Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
3TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
Daniel Junker
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Tobias Kerrinnes
4Helmholtz-Institute for RNA-based Infection Research (HIRI), Würzburg, Germany
Philipp D. Kaiser
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Bjoern Traenkle
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
16Pharmaceutical Biotechnology, University of Tuebingen, Germany
Heiko Dinter
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
16Pharmaceutical Biotechnology, University of Tuebingen, Germany
Julia Häring
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Anne Zeck
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Frank Weise
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Andreas Peter
5Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany
21Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen, Tuebingen, Germany
22German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Sebastian Hörber
5Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany
21Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen, Tuebingen, Germany
22German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Simon Fink
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Felix Ruoff
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Tamam Bakchoul
9Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany
Armin Baillot
10Niedersächsisches Landesgesundheitsamt, Department of Virology/Serology, Hannover, Germany
Stefan Lohse
11Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany
Markus Cornberg
12Department of Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany
Thomas Illig
13Hannover Unified Biobank (HUB), Hannover Medical School, Hannover, Germany
Jens Gottlieb
14Clinic for Pneumonology, Hannover Medical School, Hannover, Germany
Sigrun Smola
11Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany
André Karch
17Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
Klaus Berger
17Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
Hans-Georg Rammensee
6Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
7German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
Katja Schenke-Layland
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
18Department of Women’s Health, Research Institute for Womens’s Health, Eberhard-Karls-University, Tuebingen, Germany
19Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Annika Nelde
6Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
20Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
Melanie Märklin
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
20Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
Jonas S. Heitmann
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
20Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
Juliane S. Walz
6Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
15Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
20Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
Markus Templin
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Thomas O. Joos
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Ulrich Rothbauer
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
16Pharmaceutical Biotechnology, University of Tuebingen, Germany
Gérard Krause
2Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
3TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
Nicole Schneiderhan-Marra
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Data Availability
Raw data and analysis files are available for download as supplemental files of this manuscript
Posted August 18, 2020.
Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens
Matthias Becker, Monika Strengert, Daniel Junker, Tobias Kerrinnes, Philipp D. Kaiser, Bjoern Traenkle, Heiko Dinter, Julia Häring, Anne Zeck, Frank Weise, Andreas Peter, Sebastian Hörber, Simon Fink, Felix Ruoff, Tamam Bakchoul, Armin Baillot, Stefan Lohse, Markus Cornberg, Thomas Illig, Jens Gottlieb, Sigrun Smola, André Karch, Klaus Berger, Hans-Georg Rammensee, Katja Schenke-Layland, Annika Nelde, Melanie Märklin, Jonas S. Heitmann, Juliane S. Walz, Markus Templin, Thomas O. Joos, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra
medRxiv 2020.07.17.20156000; doi: https://doi.org/10.1101/2020.07.17.20156000
Now published in Nature Communications doi: 10.1038/s41467-021-20973-3
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (414)
- Allergy and Immunology (735)
- Anesthesia (216)
- Cardiovascular Medicine (3150)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13115)
- Forensic Medicine (15)
- Gastroenterology (875)
- Genetic and Genomic Medicine (4938)
- Geriatric Medicine (455)
- Health Economics (758)
- Health Informatics (3108)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (981)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4693)
- Nursing (249)
- Nutrition (695)
- Oncology (2421)
- Ophthalmology (689)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7258)
- Radiology and Imaging (1623)
- Respiratory Medicine (950)
- Rheumatology (463)
- Sports Medicine (408)
- Surgery (524)
- Toxicology (65)
- Transplantation (223)
- Urology (193)